SPIRIVA
Boehringer Ingelheim Pharma GmbH & Co. KG
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79002090 |
| Registration Number | 2998420 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | F |
| Attorney Name | James A. Thomas |
| Attorney Docket Number | 116A-105 |
| Law Office Assigned | M40 |
| Employee Name | LOTT, JASON E |
Timeline
| 2004-03-18 | Application Filed |
| 2005-06-28 | Published for Opposition |
| 2005-09-20 | Trademark Registered |
| 2011-09-28 | Location: GENERIC WEB UPDATE |
| 2016-04-22 | Cancelled |
| 2016-04-22 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Boehringer Ingelheim Pharma GmbH & Co. KG |
| Address | 55218 Ingelheim DE |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | Instruments and apparatus for the inhalation of medicines |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2004-05-13 | 1 REPR M: |
| NEW APPLICATION ENTERED IN TRAM | 2004-05-17 | 2 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2004-09-28 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2004-10-04 | 4 CNRT R:Renewal |
| NON-FINAL ACTION MAILED | 2004-10-06 | 5 CNRT F:First Action |
| REFUSAL PROCESSED BY IB | 2004-11-04 | 6 RFNT P: |
| PAPER RECEIVED | 2005-02-24 | 7 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-02-24 | 8 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2005-03-16 | 9 ACEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-03-16 | 10 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2005-03-22 | 11 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-03-23 | 12 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2005-06-08 | 13 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-06-28 | 14 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2005-09-20 | 15 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2006-05-19 | 16 FICR P: |
| FINAL DISPOSITION PROCESSED | 2006-07-07 | 17 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2006-07-10 | 18 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2006-07-27 | 19 FINV P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2009-09-24 | 20 CHLD M: |
| TEAS SECTION 71 RECEIVED | 2011-09-20 | 21 ES71 I:Incoming Correspondence |
| TEAS SECTION 15 RECEIVED | 2011-09-20 | 22 E15R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2011-09-22 | 23 APRE A:Allowance for Publication |
| REGISTERED - SEC. 15 ACKNOWLEDGED | 2011-09-28 | 24 15AK O:Outgoing Correspondence |
| REGISTERED-SEC.71 ACCEPTED | 2011-09-28 | 25 71AG O:Outgoing Correspondence |
| SEC. 15 ACKNOWLEDGEMENT - E-MAILED | 2011-09-28 | 26 NA15 E:E-Mail |
| NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | 2011-09-28 | 27 NA71 E:E-Mail |
| INTERNATIONAL REGISTRATION RENEWED | 2014-04-03 | 28 RNWL P: |
| CANCELLED SECTION 71 | 2016-04-22 | 29 C71T O:Outgoing Correspondence |
| TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | 2016-12-22 | 30 INTR P: |
| GENERIC MADRID TRANSACTION CREATED | 2017-02-13 | 31 XXCR P: |
| GENERIC MADRID TRANSACTION SENT TO IB | 2017-02-13 | 32 XXSS O:Outgoing Correspondence |
| TOTAL INVALIDATION PROCESSED BY THE IB | 2017-04-28 | 33 INNT P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SPIRIVA 79002090 2998420 Dead/Cancelled |
Boehringer Ingelheim Pharma GmbH & Co. KG 2004-03-18 |
 SPIRIVA 78335207 3005009 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co. KG 2003-12-02 |
 SPIRIVA 75575954 2285506 Live/Registered |
Boehringer Ingelheim Pharma GmbH & Co. K 1998-10-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 